1. Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): a double-blind, randomised, phase 3 trial. Issue 10379 (11th March 2023) Authors: Motzer, Robert J; Russo, Paul; Grünwald, Viktor; Tomita, Yoshihiko; Zurawski, Bogdan; Parikh, Omi; Buti, Sebastiano; Barthélémy, Philippe; Goh, Jeffrey C; Ye, Dingwei; Lingua, Alejo; Lattouf, Jean-Baptiste; Albigès, Laurence; George, Saby; Shuch, Brian; Sosman, Jeffrey; Staehler, Michael; Vázquez... Journal: Lancet Issue: Volume 401:Issue 10379(2023) Page Start: 821 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗